# Pelthos Therapeutics Inc.: Form 8-K, filed Apr 17, 2025

- Company: [Pelthos Therapeutics Inc.](/companies/pths.md) (CIK 1919246)
- Form: 8-K
- Filed: 2025-04-17
- Accepted by EDGAR: Apr 17, 2025, 06:11 ET
- Period: 2025-04-17
- Accession: 0001753926-25-000652
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1919246/000175392625000652/g084777_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1919246/000175392625000652/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 4.01: Change of auditor
- Item 5.07: Shareholder vote results
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1919246/000175392625000652/g084777_8k.htm

Filed Apr 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001753926-25-000652. Last ingested by Listed: Nov 3, 2026, 23:09 ET. No prices; not investment advice.